Aktie 688289 SANSURE BIOTECH INC.
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen Sansure Biotech Inc.

Aktien

688289

CNE1000043J1

688289

Schlusskurs Shanghai S.E.
Andere Börsenplätze
 00:00:00 30.04.2024 		% 5 Tage % 1. Jan.
20,46 CNY +1,49 % Intraday Chart für Sansure Biotech Inc. +11,62 % +4,65 %
26.04. Sansure Biotech Inc. meldet Ergebnis für das erste Quartal zum 31. März 2024 CI
29.02. Gewinn von Sansure Biotech fällt 2023 um 81%, Umsatz bricht um 84% ein MT

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
Sansure Biotech Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
Sansure Biotech's 2023 Profit Drops 81% as Revenue Slumps 84%
Sansure Biotech Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
ASEP Medical Holdings Signs JV Agreement with Chinese Medical Diagnostics Co Sansure Biotech Inc.
Sansure Biotech Secures EU Certification For In Vitro Diagnostic Device
Sansure Biotech Inc. Reports Earnings Results for the Nine Months Ended September 30, 2023
Tranche Update on Sansure Biotech Inc.'s Equity Buyback Plan announced on October 21, 2022.
Sansure Biotech Inc.'s Equity Buyback announced on October 21, 2022, has closed with 9,865,793 shares, representing 1.7% for CNY 200 million.
Sansure Biotech Gets EU CE certification for 60 products
Certain A Shares of Sansure Biotech Inc. are subject to a Lock-Up Agreement Ending on 28-AUG-2023.
Sansure Biotech Inc. Reports Earnings Results for the Half Year Ended June 30, 2023
Sansure Biotech's Human Papillomavirus Kit Gets EU Registration Certificate
Tranche Update on Sansure Biotech Inc.'s Equity Buyback Plan announced on October 21, 2022.
Sansure Biotech Inc.(SHSE:688289) dropped from Shanghai Stock Exchange Health Care Sector Index
Sansure Biotech Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023
Tranche Update on Sansure Biotech Inc.'s Equity Buyback Plan announced on October 21, 2022.
Sansure Biotech Inc. Reports Earnings Results for the Full Year Ended December 31, 2022
Asep Inc. Lower After Signing JV Term Sheet with Leading Chinese Medical Diagnostic Co. Sansure Biotech Inc.
Sansure Biotech Gets Certification for COVID-19 Kit
ASEP Medical Holdings Inc. Signs Joint Venture Term Sheet with Sansure Biotech Inc. in Preparation for the Commercialization of the Sepset(ER) Sepsis Diagnostic Test in China
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. 688289 Aktie
  4. Nachrichten Sansure Biotech Inc.
  5. Andere Sprachen